Skip to content

A medical records based study on the application of abiotic artificial liver therapy with hypotension based on multi-dimensional recognition and intervention system

A medical records based study on the application of abiotic artificial liver therapy with hypotension based on multi-dimensional recognition and intervention system

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043632
Enrollment
Unknown
Registered
2021-02-23
Start date
2021-02-23
Completion date
Unknown
Last updated
2021-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver failure

Interventions

case series:Nil

Sponsors

Department of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria of the study population include: 1. the age is more than 18 years old and less than 75 years old; 2. the treatment history of non biological artificial liver.

Exclusion criteria

Exclusion criteria: The exclusion criteria of the experimental research population of this subject include: 1. The patient information is missing or missing; 2. the patient information is obviously wrong. The exclusion criteria of the validation study population include: 1. Unable to inform the patient or the legal representative in an informed way; 2. due to other reasons Non biological artificial liver was used to treat the failure.

Design outcomes

Primary

MeasureTime frame
Noninvasive blood pressure;heart rate;

Secondary

MeasureTime frame
SPO2;Respiratory rate;Chief complaint;

Countries

China

Contacts

Public ContactZhang Huafen

Department of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University

zhanghuafen@zju.edu.cn+86 13757120681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026